Ibuprofen treatment versus gradual introduction of interferon β-1b in patients with MS

Neurology

Volumn 52, Issue 9, 1999, Pages 1893-1895

  Rice, G F P A ^a   Ebers, G C ^a   Lublin, F D ^b   Knobler, R L ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INTERFERON BETA SERINE; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; FLU LIKE SYNDROME; HUMAN; INJECTION SITE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0032976227     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1893     Document Type: Article

References (9)

1. The IFNB Multiple Sclerosis Study Group. Interferon beta Ib in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.
2. Kappos L, Polman C, Pozzilli C, Thompson A, Dahlke F, and the European Study Group. Placebo-controlled multicentre randomised trial of interferon beta-lb in treatment of secondary progressive multiple sclerosis: European Study Group on interferon beta-lb in secondary progressive MS. Lancet 1998;352: 1491-1497.
3. Mora JS, Kao KP, Munsat TL. Indomethacin reduces the side effects of intrathecal interferon. N Engl J Med 1997;310:126-127.
4. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
5. Donner A. Approaches to sample size estimation in the design of clinical trials: a review. Stat Med 1984;3:199-214.
6. Knobler RL, Greenstein JI, Johnson KP, et al. Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up. J Interferon Cytokine Res 1993;13:333-340.
7. Nakashima T, Hori T, Kuriyama K, Matsuda T. Effects of interferon a on the activity of the preoptic thermosensitive neurons in tissue slices. Brain Res 1988;454:361-367.
8. Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, Katafuchi T. Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 1991;27: 309-313.
9. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Interferon . beta-lb in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.